Symbol="CRSP"
AssetType="Common Stock"
Name="Crispr Therapeutics AG"
Description="CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland."
CIK="1674416"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="BAARERSTRASSE 14, ZUG, CH"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3945952000"
EBITDA="-452763008"
PERatio="None"
PEGRatio="0"
BookValue="22.88"
DividendPerShare="0"
DividendYield="0"
EPS="-5.37"
RevenuePerShareTTM="2.166"
ProfitMargin="-2.445"
OperatingMarginTTM="-2.784"
ReturnOnAssetsTTM="-0.127"
ReturnOnEquityTTM="-0.213"
RevenueTTM="170100000"
GrossProfitTTM="-570697000"
DilutedEPSTTM="-5.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="442.04"
AnalystTargetPrice="86"
TrailingPE="-"
ForwardPE="23.36"
PriceToSalesRatioTTM="253.26"
PriceToBookRatio="2.011"
EVToRevenue="178.1"
EVToEBITDA="-3.434"
Beta="1.614"
num_52WeekHigh="75.18"
num_52WeekLow="38.94"
num_50DayMovingAverage="54.23"
num_200DayMovingAverage="52.5"
SharesOutstanding="79411000"
DividendDate="None"
ExDividendDate="None"
symbol="CRSP"
open="49.82"
high="50.90"
low="49.11"
price="49.69"
volume="957584.00"
latest_trading_day="2023-08-25"
previous_close="49.65"
change="0.04"
change_percent="0.0806%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="40"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="60"
Volume_recent_avg="1261286"
Change_recent_avg="-0.1"
Delta_recent_avg="2.73"
Variance_recent_avg="1.37"
Change_ratio_recent_avg="-0.2"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="60"
Aroon_momentum_negative="40"
image_negative_thumbnail_id_1="124"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0052.jpeg"
image_negative_thumbnail_id_2="1099"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0132.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="523"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_positive_thumbnail_id_1="685"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_positive_thumbnail_id_2="656"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0052.jpeg"
image_professor_thumbnail_id_1="1200"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0034.jpeg"
image_professor_thumbnail_id_2="1189"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0023.jpeg"
